- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 16:42 | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | 1 | pulse2.com | ||
| Mi | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 17.07. | Glucotrack Gains Slightly on Bridge Financing Deal | - | Baystreet.ca | ||
| 17.07. | Glucotrack completes bridge financing after merger | 1 | Investing.com | ||
| 17.07. | Glucotrack schließt Brückenfinanzierung nach Unternehmenszusammenschluss ab | 2 | Investing.com Deutsch | ||
| 17.07. | GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On | 2 | Benzinga.com | ||
| 16.07. | Glucotrack completes business combination with Lokahi Therapeutics | 3 | Investing.com | ||
| 15.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.07. | Glucotrack combines with Lokahi Therapeutics to become CBGM subsidiary | - | MassDevice | ||
| 14.07. | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | 257 | GlobeNewswire (Europe) | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| 27.05. | Glucotrack CEO explains tech behind long-term CBGM implant | 12 | MassDevice | ||
| 15.05. | Glucotrack reports Q1 results | 1 | Seeking Alpha | ||
| 14.05. | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | 605 | GlobeNewswire (Europe) | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| 14.05. | Glucotrack, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 14.05. | Glucotrack, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 07.05. | Glucotrack submits long-term implantable CBGM for FDA IDE | - | MassDevice | ||
| 07.05. | Glucotrack beantragt FDA-Zulassung für implantierbaren Blutzuckermonitor | 4 | Investing.com Deutsch | ||
| 07.05. | Glucotrack, Inc.: Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology | 272 | GlobeNewswire (Europe) | RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization... ► Artikel lesen | |
| 30.04. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,600 | -0,22 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,070 | +5,11 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,010 | -7,27 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| HEALWELL AI | 0,438 | +3,31 % | HEALWELL AI kündigt Telefonkonferenz zur Erörterung der Finanzergebnisse des zweiten Quartals 2026 für den 7. August 2026 an | HEALWELL AI wird am Freitag, den 7. August 2026, um 8:30 Uhr ET (5:30 Uhr PT) eine Telefonkonferenz und einen gleichzeitigen Webcast
abhalten
TORONTO, ON, 4. August 2026... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA | Total revenue increased 60% year over year to $6.4 millionNet loss per share decreased 88% compared to the prior-year quarterGross margin expanded to 40% as operating expenses remained stableFDA clearance... ► Artikel lesen | |
| UNIDOC HEALTH | 0,053 | -0,37 % | Ventripoint Diagnostics Ltd (2): Ventripoint, UniDoc assess remote cardiac platform | ||
| CO-DIAGNOSTICS | 1,440 | -4,64 % | Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test | Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings
SALT LAKE... ► Artikel lesen | |
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUEST DIAGNOSTICS | 203,70 | -0,24 % | Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates | ||
| QUIDELORTHO | 14,310 | -5,51 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| VERU | 2,335 | +0,21 % | Veru Inc.: Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss | ||
| LIFEWARD | 7,280 | 0,00 % | Lifeward Ltd.: Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk Personal Exoskeleton | ||
| SENSEONICS | 4,500 | +0,45 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,082 (-15,52 %) liegt der Kurs bei 0,444 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.